{"id":212,"date":"2011-10-08T18:46:17","date_gmt":"2011-10-08T18:46:17","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=212"},"modified":"2026-02-25T20:51:40","modified_gmt":"2026-02-25T20:51:40","slug":"histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/","title":{"rendered":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco)"},"content":{"rendered":"

Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder associated to mental retardation and caused by mutations in the genes CREBBP <\/em>and EP300<\/em> encoding for the transcriptional regulators CBP and p300, respectively. These proteins regulate the acetylation state of the chromatin and consequently affect gene expression. Previous studies have shown that neuronal histone acetylation is reduced in mouse models of RSTS. In this article, Lopez-Atalaya and colleagues identify a number of new mutations into the CREBBP<\/em> gene associated to RSTS widening the spectrum of mutations associated to this disorder and investigate for possible histone acetylation deficits in lymphoblastoid cell lines derived from some of these patients. The confirmation of the existence of similar biochemical deficits in cell lines from patients and mouse models of the disease and the efficacy of HDAC inhibitors to reverse these deficits opens new therapeutic possibilities. \u00a0(http:\/\/jmg.bmj.com\/content\/early\/2011\/10\/07\/jmedgenet-2011-100354.abstract?papetoc<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder associated to mental retardation and caused by mutations in the genes CREBBP and EP300 encoding for the transcriptional regulators CBP and p300, respectively. These proteins regulate the acetylation state of the chromatin and consequently affect gene expression. Previous studies have shown that neuronal histone acetylation is reduced in […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-212","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nHistone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein\u2013taybi-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder associated to mental retardation and caused by mutations in the genes CREBBP and EP300 encoding for the transcriptional regulators CBP and p300, respectively. These proteins regulate the acetylation state of the chromatin and consequently affect gene expression. Previous studies have shown that neuronal histone acetylation is reduced in [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein\u2013taybi-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2011-10-08T18:46:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T20:51:40+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco)\",\"datePublished\":\"2011-10-08T18:46:17+00:00\",\"dateModified\":\"2026-02-25T20:51:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/\"},\"wordCount\":166,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/\",\"name\":\"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2011-10-08T18:46:17+00:00\",\"dateModified\":\"2026-02-25T20:51:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/10\\\/08\\\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein\u2013taybi-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog","og_description":"Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder associated to mental retardation and caused by mutations in the genes CREBBP and EP300 encoding for the transcriptional regulators CBP and p300, respectively. These proteins regulate the acetylation state of the chromatin and consequently affect gene expression. Previous studies have shown that neuronal histone acetylation is reduced in [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein\u2013taybi-syndrome\/","og_site_name":"JMG Contact blog","article_published_time":"2011-10-08T18:46:17+00:00","article_modified_time":"2026-02-25T20:51:40+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco)","datePublished":"2011-10-08T18:46:17+00:00","dateModified":"2026-02-25T20:51:40+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/"},"wordCount":166,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/","url":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/","name":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2011-10-08T18:46:17+00:00","dateModified":"2026-02-25T20:51:40+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/10\/08\/histone-acetylation-deficits-in-lymphoblastoid-cell-lines-from-patients-with-rubinstein%e2%80%93taybi-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome (Contributed by Dr. Angel Barco)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=212"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/212\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}